- Full Time Employees
- 1
- Sector
- Finance
- Industry
- Investment banks/Brokers
- Address
- Coimbatore India
- IPO Date
- Aug 22, 2005
- Business
- ABATE AS Industries Limited is an India-based diversified healthcare and commercial enterprise primarily engaged in the provision of tertiary ophthalmic healthcare services, optical vision care solutions, professional healthcare education, and multi-channel retail and corporate advisory operations. Founded in 1991 and headquartered in Perinthalmanna, Kerala, India, the company operates across key business segments that include Healthcare, Optical Solutions, Education and Training, Commercial Retail, and Advisory Services. The company offers a comprehensive portfolio of products and services, including super-specialty eye care treatments covering cataract surgeries, vitreoretinal procedures, glaucoma diagnostics and management, refractive and LASIK surgeries, pediatric ophthalmology, corneal care, oculoplasty, neuro-ophthalmology, and advanced ophthalmic diagnostics; prescription eyewear, spectacle frames, progressive and corrective ophthalmic lenses, contact lenses, sunglasses, and optical accessories distributed through specialized vision centers; allied health sciences education, including degree-level Optometry programs and clinical healthcare training certifications; consumer retail merchandising covering daily consumer goods, department store retail, and mobile accessories; and corporate advisory services spanning architectural planning, marketing consultancy, and capital market guidance. The company conducts its flagship healthcare and eye hospital network operations through its subsidiary, Prudential Management Services Limited, serving patients, consumers, and institutional clients across India and expanding into international markets, including the Middle East. In recent corporate developments, the company completed a strategic restructuring and corporate rebranding from Trijal Industries Limited to ABATE AS Industries Limited, pivoting its primary operational focus from legacy financial trading to advanced healthcare delivery and retail optical services. The company further strengthened its capital base through a one-for-one (1:1) bonus equity share issuance approved in 2025 to increase shareholder value and enhance stock liquidity, while pursuing capital expenditure initiatives aimed at expanding its specialized eye hospital footprint, scaling its optical retail presence internationally in markets such as Bahrain, deploying next-generation 3D surgical visualization technologies, and developing a dedicated private healthcare university institution.